Zydus Lifesciences Limited — Results, 05-02-2025: Integrated Filing- Financial

Zydus Lifesciences Limited has reported its financial results for the quarter and nine months ended December 31, 2024. Total revenue from operations rose to ₹52,691 million, up from ₹45,052 million year-over-year, driven by strong sales growth across its Pharmaceuticals segment. Profit before tax was ₹11,841 million, while net profit stood at ₹10,238 million. The company has managed operational efficiency, reflected in a solid profit margin despite rising costs. This robust performance may bolster investor confidence, indicating a positive outlook for future growth. Investors should remain alert to potential risks tied to fluctuating raw material costs and regulatory changes.